BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now
Advanced Search

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

10 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, Virtual Screening, and Synthesis of Antagonists ofaIIbß3 as Antiplatelet Agents.EBI
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine
Small Macrocycles As Highly Active Integrinα2β1 Antagonists.EBI
Sanofi R & D
Small molecule designed to target metal binding site in the alpha2I domain inhibits integrin function.EBI
University of Turku
Derivatives of 7-amino-1,2,3,4-tetrahydroisoquinoline and isophthalic acids as novel fibrinogen receptor antagonists.EBI
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine
RGD mimetics containing phthalimidine fragment as novel ligands of fibrinogen receptor.EBI
A.V. Bogatsky Physico-Chemical Institute of The National Academy of Sciences of Ukraine
Novel inhibitors of the alphavbeta3 integrin--lead identification strategy.EBI
Astrazeneca
Pseudoprolines as stereoelectronically tunable proline isosteres.EBI
Bristol Myers Squibb
Insights into Protein-Ligand Interactions in Integrin Complexes: Advances in Structure Determinations.EBI
Pliant Therapeutics
Strategies to inhibit tumor associated integrin receptors: rationale for dual and multi-antagonists.EBI
University of Bradford
Imide and acylurea derivatives as modulators of the glucocorticoid receptorBDB
Bristol-Myers Squibb